Active-ingredient Dossier
Tenofovir Disoproxil Fumarate
Active-ingredient Dossier for Tenofovir Disoproxil Fumarate (nucleotide reverse transcriptase inhibitor). Australian brands, products, PBS listings, PBAC…
- Brand: STRIBILD
- Brand: EVIPLERA
- Brand: APO-TENOFOVIR
- Brand: VIREAD
- Brand: TRUVADA
- Brand: TENOFOVIR ARX
- Therapeutic area: Infectious Disease
What is
Tenofovir Disoproxil Fumarate Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor.
Australian brands containing
Tenofovir Disoproxil Fumarate — TRUVADA — STRIBILD — EVIPLERA — APO-TENOFOVIR — VIREAD — TENOFOVIR ARX
Therapeutic areas
Tenofovir Disoproxil Fumarate is registered in infectious disease, with 13 brands containing this ingredient on the ARTG.
Sponsor landscape
Five sponsors market Tenofovir Disoproxil Fumarate in Australia: Hetero, Gilead Sciences, Arrotex Pharmaceuticals, GM Pharma, and Cipla.
PBS and regulatory activity
The latest PBAC outcome for Tenofovir Disoproxil Fumarate was recorded on 1 December 2017, with 3 brands having PBAC outcomes on record. The latest AusPAR is dated 2 May 2016, with 3 brands having AusPARs on record.